Systematic Review

Published on 24 Nov 2022

Cardiovascular and renal outcomes with sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus: A system review and network meta-analysis

in Renal Pharmacology

Lei Tian
Sinan Ai
Huijuan zheng
Hanwen Yang
Mengqi Zhou
Jingyi Tang
Weijing Liu
Wenjing Zhao
Yaoxian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.986186

5,747 views
3 citations

Original Research

Published on 23 Nov 2022

Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury

in Renal Pharmacology

Jiajia Li
Yupeng Jiang
Qin Dai
Yue Yu
Xin Lv
Yan Zhang
Xiaohua Liao
Liyun Ao
Gaoyun Hu
Jie Meng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1043945

3,032 views
10 citations

Original Research

Published on 22 Nov 2022

Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials

in Renal Pharmacology

Suiyuan Hu
Chu Lin
Xiaoling Cai
Xingyun Zhu
Fang Lv
Wenjia Yang
Linong Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1018720

2,086 views
2 citations

Review

Published on 22 Nov 2022

The critical role of the Hippo signaling pathway in kidney diseases

in Renal Pharmacology

Yuting Sun
De Jin
Ziwei Zhang
Di Jin
JiaoJiao Xue
LiYun Duan
YuQing Zhang
XiaoMin Kang
FengMei Lian

Frontiers in Pharmacology

doi 10.3389/fphar.2022.988175

5,834 views
12 citations

Review

Published on 17 Nov 2022

Ferroptosis: A new insight for treatment of acute kidney injury

in Renal Pharmacology

Shiyang Li
Rui Wang
Yixue Wang
Yong Liu
Yingjin Qiao
Peipei Li
Jingfang Chen
Shaokang Pan
Qi Feng
Zhangsuo Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1065867

5,747 views
17 citations

Original Research

Published on 16 Nov 2022

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages

in Renal Pharmacology

Xu Guan
Yong Liu
Wang Xin
Shaozong Qin
Shuiqin Gong
Tangli Xiao
Daohai Zhang
Yan Li
Jiachuan Xiong
Ke Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1030800

4,142 views
4 citations

Original Research

Published on 15 Nov 2022

Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction

in Renal Pharmacology

Qiongbo Huang
Xiaobin Lin
Yang Wang
Xiujuan Chen
Wei Zheng
Xiaoli Zhong
Dewei Shang
Min Huang
Xia Gao
Hui Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.942129

4,143 views
9 citations

Review

Published on 09 Nov 2022

Osteopontin: An important protein in the formation of kidney stones

in Renal Pharmacology

Qingxia Jia
Ziye Huang
Guang Wang
Xia Sun
Yuyun Wu
Bowei Yang
Tongxin Yang
Jianhe Liu
Pei Li
Jiongming Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1036423

4,611 views
10 citations

Original Research

Published on 03 Nov 2022

Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis

in Renal Pharmacology

Bingbing Hou
Mingming Liu
Yang Chen
Weijian Ni
Xiaoguo Suo
Yuexian Xu
Qiushi He
Xiaoming Meng
Zongyao Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1041117

2,202 views
8 citations

Review

Published on 03 Nov 2022

Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease

in Renal Pharmacology

Dan-Qian Chen
Jun Wu
Ping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1055296

6,593 views
15 citations

Review

Published on 02 Nov 2022

Cellular phenotypic transitions in diabetic nephropathy: An update

in Renal Pharmacology

Yiling Cao
Ji-Hong Lin
Hans-Peter Hammes
Chun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1038073

4,170 views
12 citations

Review

Published on 02 Nov 2022

Selecting the right therapeutic target for kidney disease

in Renal Pharmacology

Lisa Buvall
Robert I. Menzies
Julie Williams
Kevin J. Woollard
Chanchal Kumar
Anna B. Granqvist
Maria Fritsch
Denis Feliers
Anna Reznichenko
Davide Gianni

Frontiers in Pharmacology

doi 10.3389/fphar.2022.971065

6,706 views
6 citations

Correction

Published on 01 Nov 2022

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

in Renal Pharmacology

Qiang Wang
Yuemei Xi
Binyang Chen
Hairong Zhao
Wei Yu
De Xie
Weidong Liu
Furong He
Chenxi Xu
Jidong Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1022539

1,067 views
1 citation

Editorial

Published on 28 Oct 2022

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II

in Renal Pharmacology

Dan-Qian Chen
Yan Guo
Zhi-Yong Guo
Yu-Ping Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053408

1,156 views
2 citations

Original Research

Published on 28 Oct 2022

Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking

in Renal Pharmacology

Lingfei Lu
Jinting Peng
Peijun Wan
Hongcheng Peng
Jiandong Lu
Guoliang Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.940773

3,943 views
4 citations

Original Research

Published on 21 Oct 2022

Oral energy supplementation improves nutritional status in hemodialysis patients with protein–energy wasting: A pilot study

in Renal Pharmacology

Aiya Qin
Jiaxing Tan
Wen Hu
Yuan Liu
Lin Chen
Yi Tang
Wei Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.839803

3,048 views
3 citations

Navigation group

Articles

Cardiovascular and renal outcomes with sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus: A system review and network meta-analysis

Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury

Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials

The critical role of the Hippo signaling pathway in kidney diseases

Ferroptosis: A new insight for treatment of acute kidney injury

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages

Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction

Osteopontin: An important protein in the formation of kidney stones

Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis

Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease

Cellular phenotypic transitions in diabetic nephropathy: An update

Selecting the right therapeutic target for kidney disease

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II

Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking

Oral energy supplementation improves nutritional status in hemodialysis patients with protein–energy wasting: A pilot study